Table 1 Antihypertensive drugs used among 1,875 pregnant women with HDP in the TMM BirThree cohort study

Any antihypertensives

55

2.9

Any antihypertensives

55

2.9

Any antihypertensives

63

3.4

 Amlodipine

18

32.7

Methyldopa^a

42

76.4

Methyldopa^a

51

81.0

 Methyldopa^a

17

30.9

Hydralazine^a

8

14.5

Hydralazine^a

10

15.9

 Nifedipine^a

7

12.7

Labetalol^a

8

14.5

Nifedipine^a

10

15.9

 Hydralazine^a

5

9.1

Amlodipine

4

7.3

Labetalol^a

8

12.7

 Candesartan

4

7.3

Nifedipine^a

1

1.8

Amlodipine

2

3.2

 Labetalol^a

3

5.5

Spironolactone

1

1.8

Atenolol

1

1.6

 Valsartan

3

5.5

Propranolol

1

1.8

Betaxolol

1

1.6

 Benidipine

3

5.5

Betaxolol

1

1.8

 Propranolol

2

3.6

Candesartan

1

1.8

 Furosemide

1

1.8

Trichlormethiazide

1

1.8

 Losartan

1

1.8

Eplerenone

1

1.8

 Spironolactone

1

1.8

Azelnidipine

1

1.8

 Irbesartan

1

1.8

 Betaxolol

1

1.8

 Telmisartan

1

1.8

 Azelnidipine

1

1.8

 Cilnidipine

1

1.8

 Urapidil

1

1.8

 Azilsartan

1

1.8